Bottom line
How has EMLAX performed?
As of Dec 31, 2025, EMLAX returned +14.1% over the past year, +0.6% a year over five years, +3.7% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $14,300. Its five-year return beat 18% of emerging-markets bond funds we track. Its best quarter was +11.8% and its worst −18.9%.
Updated Dec 31, 2025
EMLAX annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| EMLAX | +19.2% | −4.4% | +13.2% | −9.0% | −8.3% | +2.4% | +15.8% | −6.4% | +14.4% | +9.5% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in EMLAX
$10,000 invested at the start of 2016 would have been worth about $15,000 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +19.2% | $14,975 |
| 2024 | −4.4% | $12,567 |
| 2023 | +13.2% | $13,147 |
| 2022 | −9.0% | $11,612 |
| 2021 | −8.3% | $12,757 |
| 2020 | +2.4% | $13,912 |
| 2019 | +15.8% | $13,581 |
| 2018 | −6.4% | $11,732 |
| 2017 | +14.4% | $12,530 |
| 2016 | +9.5% | $10,949 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| EMLAX | +14.1% | +0.6% | +3.7% | — |
| Emerging-Markets Bond median | +14.5% | +1.6% | +4.0% | — |
Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jul 31, 2026, EMLAX returned +0.87%, +0.54%, +0.20% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.